We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04138875
Brief Title: A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)

First Submitted : October 23, 2019
First Submitted that Met QC Criteria : October 23, 2019
First Posted : October 25, 2019

Last Update Submitted that Met QC Criteria : June 21, 2022
Last Update Posted : June 23, 2022